Expression of tissue factor and tissue factor pathway inhibitor in microparticles and subcellular fractions of normal and malignant prostate cell lines-Reference-Cited by-同舟云学术

Expression of tissue factor and tissue factor pathway inhibitor in microparticles and subcellular fractions of normal and malignant prostate cell lines

Published:2013-04 Issue:3 Volume:24 Page:339-343
ISSN:0957-5235
Container-title:Blood Coagulation & Fibrinolysis
language:en
Short-container-title:

Author:

Lwaleed Bashir A.,Lam Lilian,Lasebai Muayed,Cooper Alan J.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hematology,General Medicine

Reference31 articles.

1. Cancer and coagulation.;Khorana;Am J Hematol,2012

2. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer.;Akl;Cochrane Database Syst Rev,2011

3. Trousseaus syndrome and other manifestations of chronic DIC in patients with neoplasms.;Sack;Medicine,1977

4. Procoagulant activity may be a marker of the malignant phenotype in experimental prostate cancer.;Adamson;Br J Cancer,1994

5. Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer.;Haubold;Thromb Haemost,2009

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bleeding and Thrombosis in Multiple Myeloma: Platelets as Key Players during Cell Interactions and Potential Use as Drug Delivery Systems;International Journal of Molecular Sciences;2023-11-01

2. Hypercoagulability and Thrombosis Risk in Prostate Cancer: The Role of Thromboelastography;Seminars in Thrombosis and Hemostasis;2022-11-21

3. Tumor Cell-Induced Platelet Aggregation as an Emerging Therapeutic Target for Cancer Therapy;Frontiers in Oncology;2022-06-23

4. Down-regulation of tissue factor inhibits invasion and metastasis of non-small cell lung cancer;Journal of Cancer;2020

5. Microparticles and Fibrinolysis;Seminars in Thrombosis and Hemostasis;2016-12-06